| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0006 |